Similar articles

• A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.

  Li H, Rui Q, Ning X, Xu H, Gu N. Li H, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1002-8. doi: 10.1016/j.pnpbp.2011.02.001. Epub 2011 Feb 18. Prog Neuropsychopharmacol Biol Psychiatry. 2011. PMID: 21315787 Clinical Trial.
• Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.

  Fu DJ, Bossie CA, Sliwa JK, Ma YW, Alphs L. Fu DJ, et al. Int Clin Psychopharmacol. 2014 Jan;29(1):45-55. doi: 10.1097/YIC.0000000000000006. Int Clin Psychopharmacol. 2014. PMID: 24113628 Clinical Trial.
• Expanding Therapy With Long-Acting Antipsychotic Medication in Patients With Schizophrenia.

  Carpenter WT Jr, Buchanan RW. Carpenter WT Jr, et al. JAMA Psychiatry. 2015 Aug;72(8):745-6. doi: 10.1001/jamapsychiatry.2015.0485. JAMA Psychiatry. 2015. PMID: 26107157 No abstract available.
• Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia.

  Gilday E, Nasrallah HA. Gilday E, et al. Rev Recent Clin Trials. 2012 Feb;7(1):2-9. doi: 10.2174/157488712799363307. Rev Recent Clin Trials. 2012. PMID: 22023179 Review.
• Paliperidone palmitate for schizophrenia.

  Nussbaum AM, Stroup TS. Nussbaum AM, et al. Schizophr Bull. 2012 Nov;38(6):1124-7. doi: 10.1093/schbul/sbs099. Epub 2012 Sep 10. Schizophr Bull. 2012. PMID: 22966147 Free PMC article. Review. No abstract available.